AI Research2 months ago
Revolution Medicines Partners With Iambic in $25M AI Drug Discovery Deal
Revolution Medicines (Nasdaq: RVMD) and Iambic Therapeutics have announced a multi-year technology and research collaboration to develop novel drug candidates using...
